David Moatazedi
Director at Biomerica Inc (BMRA); See Remarks at Evolus, Inc. (EOLS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$2K
Total bought / sold$16K / $1.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | EOLSEvolus, Inc. | Sell | 105,108499,592 held (−17%) | $9.04 | $950K | -14.5% |
| Aug 27SEC | BMRABiomerica Inc | Buy | 10,00040,625 held (+33%) | $1.60 | $16K | +15.0% |
| Mar 20SEC | EOLSEvolus, Inc. | Sell Plan | 13,669604,700 held (−2%) | $4.75 | $65K | +62.7% |
| Mar 18SEC | EOLSEvolus, Inc. | Sell Plan | 116,720618,369 held (−16%) | $4.89 | $571K | +58.1% |
| Dec 29SEC | EOLSEvolus, Inc. | Sell Plan | 10,539354,388 held (−3%) | $7.15 | $75K | +8.1% |
- Buy
Director David Moatazedi bought $16K of BMRA at $1.60 — first open-market purchase in our records; raises the stake by 33%.
- Sell
See Remarks David Moatazedi sold $65K of EOLS at $4.75 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks David Moatazedi sold $571K of EOLS at $4.89 — pre-scheduled 10b5-1 plan sale.
- Sell
See Remarks David Moatazedi sold $75K of EOLS at $7.15 — pre-scheduled 10b5-1 plan sale.